Homeworks writing service

An introduction to sell in combo or not

Share Practitioners of fundamental and technical analysis are often at loggerheads with each other about the relative merits of their analytical methods.

Written By

Technical analysts or market technicians, on the other hand, are primarily interested in the stock price and use technical indicators such as moving averages and momentum to predict future price moves. Related Introduction To Fundamental Analysis The objective of both groups, however, is the sameā€”to generate profits by buying low and selling an introduction to sell in combo or not, or buying high and selling higher. Rather than viewing the fundamental and technical approach as competing schools of analyses, they should be viewed as complementary practices that when combined, can greatly strengthen the case for buying or selling a stock or security.

According to the growing number of market professionals who use both methods, fundamental analysis helps identify which stocks to buy or sell shortwhile technical analysis helps determine when to initiate the long or short position. Please note that this by no means a recommendation to buy or sell the stock; the analysis is being presented strictly for educational purposes. The company was incorporated in 1911 as the Computing-Tabulating-Recording Co.

IBM was a pioneer in information technology, and its ubiquitous mainframe computers made it the dominant force in computing for decades. But the personal computing revolution in the 1980s and the widespread adoption of the client-server model of distributed computing in the 1990s posed major challenges for IBM.

Introduction To Order Types: Duration

Big Blue not only survived these challenges, but an introduction to sell in combo or not by focusing on integrated business solutions systems that link the many different aspects of a business such as finance, marketing, and human resources together. IBM also stayed relevant by making a concerted push into technology services and software. The question is whether Big Blue's best days are behind it.

In 2013 and 2014, IBM was in the unusual position of being the worst performer among the 30 stocks that constitute the Dow Jones Industrial Average.

Although value investors may perceive IBM's decline as a buying opportunity, the more cynical may view the stock's drop as a lack of investor confidence in IBM's capability to compete in big growth areas like cloud computing and mobile applications.

Cross-Selling and Upselling: The Marketing Combo You Need to Know

So who's right in their outlook for the stock? Perhaps fundamental and technical analyses may provide the answer. We begin by evaluating IBM's financial performance in its most recent quarter and fiscal year. The revenue decline was due to two factors: Adjusting an introduction to sell in combo or not these two factors, 2014 revenue fell by 1 percent. On the positive side, operating gross margin non-GAAP increased by 60 basis points to 53.

This represented 27 percent of the company's total revenue. Cash Flow and Balance Sheet: IBM's growth trends are not favorable, reflecting an introduction to sell in combo or not fact that the company is in the midst of a transition. The sustained revenue decline is largely due to IBM's divestiture of non-core businesses, such as the low-end server business and an unprofitable chip-manufacturing unit. As well, based on the mid-point of the company's 2015 earnings-per-share guidance, which represents a 2.

IBM's longer-term objectives are for revenue growth in the low single digits and earning-per-share growth in the high single digits. A key concept in fundamental valuation is coming up with a list of similar companies to generate comparable valuations, also called comps.

What about the price-to-sales ratio?

In fiscal year 2014, IBM had an operating gross margin of 50. One criticism of IBM is that in 2013 and 2014, it spent much less on capital expenditures than it did on dividends and buybacks.

How to Do the Fundamental And Technical Combo Trade

In those two years, it also spent significantly less than its peers on research and development as a percentage of revenues. Over time, this could erode the company's competitive position in the fast-changing technology field. In comparison, IBM's competitors like Google, Cisco, and Oracle spend about 13 percent of revenues on research and development.

IBM has a enviable record of long-term dividend growth, having paid dividends since 1913.

As of March 2015, the company had boosted dividends at a 15 percent annual pace over the last five years. How do the analysts who cover IBM rate the stock? Of the 32 analysts who cover IBM, only five rated it as a Buy or equivalent, while 22 rated it as a Hold and five rated it as a Sell.

Technical Analysis Moving Averages: The stock has recovered since then, having broken above its 50-day moving average and in the process of testing its 100-day moving average. The technical picture has been bearish since the stock peaked in March 2013, with lower highs and lower lows; this pattern was interrupted in the fourth quarter of 2013 and first quarter of 2014, but resumed thereafter.

The stock's 14-day RSI as of March 2, 2015 was 51. The fundamental outlook could thus be construed as neutral to modestly bullish, with the stock likely to be supported by its long-term dividend growth, as well as share buybacks.

It shows IBM having broken through support on the downside and on course to test its longer-term moving averages. The differing viewpoints an introduction to sell in combo or not by fundamental and technical analysis can thus be combined to make the following conclusion--while IBM is fundamentally a solid stock, the technical picture is not bullish and the stock has downside risk in the an introduction to sell in combo or not term, which means that it may not be advisable to initiate a long position in the stock at the present time.

The takeaway here is that fundamental and technical analysis, when combined, can provide a potent buy or sell signal if they both reach the same conclusion independently. But if they provide differing results, it may be preferable to err on the side of caution and stay on the sidelines for a while, rather than acting in haste. Get a free 10 week email series that will teach you how to start investing. Delivered twice a week, straight to your inbox.